INTERVIEW: Payor-Attractive Data To Drive Uptake of HeartFlow’s FFRCT
This article was originally published in Clinica
Executive Summary
It might be up against much bigger competitors such as Philips and St Jude Medical but HeartFlow is confident that in a couple of years, its noninvasive fractional flow reserve (FFR) assessment technology will be widely used by physicians for optimizing interventional cardiovascular therapies.